{"id":"W3004333995","doi":"10.14740/wjon1241","title":"Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone","year":2020,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Vanderbilt University Medical Center; Vanderbilt University","keywords":"Medicine; Bortezomib; Nelfinavir; Proteasome inhibitor; Multiple myeloma; Dexamethasone; Lenalidomide; Refractory (planetary science); Proteasome; Oncology; Pharmacology; Cancer research; Internal medicine; Immunology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001719794,0.000292836,0.0004489156,0.0003101554,0.0002983911,0.0003226189,0.0003177114,0.0003001275,0.0003476451],"category_scores_gemma":[0.0002157362,0.00007501643,0.0003568653,0.0002157942,0.0001925579,0.0002256172,0.0004221924,0.0005657826,0.0001609723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002807142,"about_ca_system_score_gemma":0.0002714366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003821352,"about_ca_topic_score_gemma":0.001201751,"domain_scores_codex":[0.9999062,0.0000150935,0.00001255019,0.0000163629,0.00002420024,0.00002564332],"domain_scores_gemma":[0.9999528,0.000006812425,0.00001373114,0.000005826676,0.000004659553,0.00001625638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.001604937,0.001911466,0.01837582,0.001593283,0.0003676382,0.06924076,0.0007228054,0.002452572,0.1718574,0.00221006,0.004645973,0.7250171],"study_design_scores_gemma":[0.002992554,0.01390002,0.07105148,0.0008289229,0.000812932,0.4035203,0.0009793758,0.01045835,0.1761068,0.004619965,0.3146,0.0001292762],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8726983,0.1053125,0.009583686,0.002093964,0.0004372078,0.00031213,0.00008211761,0.0002841989,0.009195901],"genre_scores_gemma":[0.9741651,0.01946746,0.003782931,0.0005802457,0.0001994641,0.00004676618,0.0001137379,0.00001585275,0.001628373],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0004489156,"threshold_uncertainty_score":0.002036691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03871034861272023,"score_gpt":0.3169032622663106,"score_spread":0.2781929136535904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}